| http://www.w3.org/ns/prov#value | - Although chronic inflammation, including inflammatory bowel disease, can be a precursor to CRC development, a pronounced anti-tumour CD3 +ve T-cell response is the best predictor of long-term survival for CRC patients [51], and the generation of antigen-specific cytotoxic T lymphocyte immunotherapy has been suggested as a possible treatment for several cancers [52].
|
